Inventor
CASHMAN NEIL R
CA26 patents
⚠️ This page may combine multiple inventors who share the name “CASHMAN NEIL R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV BRITISH COLUMBIA
15 patentsUS9849165B2Dec 26, 2017
Oligomer-specific amyloid beta epitope and antibodies
UNIV BRITISH COLUMBIA5 citations83
US10751382B2Aug 25, 2020
Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
UNIV BRITISH COLUMBIA5 citations72
US10774120B2Sep 15, 2020
Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
UNIV BRITISH COLUMBIA4 citations71
US11779629B2Oct 10, 2023
Compositions comprising cyclic peptides derived from an A-beta peptide
UNIV BRITISH COLUMBIA0 citations62
US12173055B2Dec 24, 2024
N-terminal epitopes in amyloid beta and conformationally-selective antibodies thereto
UNIV BRITISH COLUMBIA0 citations60
US11970522B2Apr 30, 2024
Cyclic compound/peptide comprising an A-beta15-18 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-BETA15-18 peptide
UNIV BRITISH COLUMBIA0 citations60
US11905318B2Feb 20, 2024
Cyclic compound/peptide comprising an A-beta13-16 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-beta13-16 peptide
UNIV BRITISH COLUMBIA0 citations60
US12404321B2Sep 2, 2025
Conformation-specific epitopes in alpha-synuclein, antibodies thereto and methods related thereof
UNIV BRITISH COLUMBIA0 citations57
US12071472B2Aug 27, 2024
Methods of reducing toxicity induced by Amyloid beta (A-beta) oligomers using antibodies specific to A-beta oligomers
UNIV BRITISH COLUMBIA0 citations54
US12559548B2Feb 24, 2026
Antibodies to misfolded TDP-43 and methods of use
UNIV BRITISH COLUMBIA0 citations51
US10772969B2Sep 15, 2020
N-terminal epitopes in amyloid beta and conformationally-selective antibodies thereto
UNIV BRITISH COLUMBIA0 citations50
US10759837B2Sep 1, 2020
Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
UNIV BRITISH COLUMBIA0 citations50
US11214613B2Jan 4, 2022
Epitopes in the RNA recognition motif 1 (RRM1) of TDP-43 and misfolding-selective antibodies thereto
UNIV BRITISH COLUMBIA0 citations45
US12286469B2Apr 29, 2025
Humanized antibodies binding to amyloid-beta (A-beta)
UNIV BRITISH COLUMBIA0 citations44
US10475525B2Nov 12, 2019
Methods and systems for predicting misfolded protein epitopes
UNIV BRITISH COLUMBIA0 citations33
CASHMAN NEIL R
3 patentsUS9216217B2Dec 22, 2015
Oligomer-specific amyloid beta epitope and antibodies
CASHMAN NEIL R7 citations82
US8778885B2Jul 15, 2014
Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
CASHMAN NEIL R12 citations81
US8709422B2Apr 29, 2014
Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
CASHMAN NEIL R11 citations81
PROMIS NEUROSCIENCES INC
3 patentsUS9637552B2May 2, 2017
Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
PROMIS NEUROSCIENCES INC9 citations80
US9296819B2Mar 29, 2016
Antibodies and conjugates that target misfolded prion protein
PROMIS NEUROSCIENCES INC1 citations42
US10053510B2Aug 21, 2018
FasR antibodies and methods of use
PROMIS NEUROSCIENCES INC0 citations33